LAA and PFO Closure: Interventional Prevention of Cardioembolic Stroke

Interventional prevention of cardioembolic stroke

Russian National Congress of Cardiology

Congreso InterAmericano De Cardiology - Sociedad Interamericana de Cardiologia

European Society of Cardiology (ESC)

Intravascular Lithotripsy May Offer Solution for Calcified Coronary Lesions. Shockwave Medical technology uses sonic bursts to break up calcium in coronary arteries.

Here is the list of the most popular articles and videos on the Diagnostic and Interventional Cardiology (DAIC) magazine website from the month of April 2018. This is based on website analytics of the month’s 176,183 pageviews:

1. Intravascular Lithotripsy May Offer Solution for Calcified Coronary Lesions

April 30, 2018 — LivaNova announced it completed the sale of its cardiac rhythm management (CRM) business to MicroPort Scientific Corp. for $190 million in cash. 

The CRM business was previously owned by Sorin, which merged with Cyberonics Inc. in 2015 to form LivaNova. Sorin had previously purchased to the CRM portfolio of Ela Medical. 

Mandatory public reporting of coronary artery bypass grafting (CABG) results in Massachusetts was associated with better patient outcomes compared to national findings, according to a recent study. Results of the 13-year Massachusetts experience were presented in a plenary session of the American Association for Thoracic Surgery’s 98th Annual Meeting.

A patient case study showing a venous ulcer formation 18 months following thermal ablation varicose vein treatment in the GSV. The patient was treated with Varithena polidocanol endovenous microfoam chemical-ablation. Images show baseline prior to treatment (right), followed by one, four and six weeks after treatment. The treatment is also called sclerotherapy.

The introduction of thermal ablation revolutionized the treatment of varicose veins, yet recurrence remains a stubborn problem. A 2016 review of three randomized controlled trials (RCTs) involving radiofrequency (RF) ablation and five RCTs employing endovenous laser therapy (EVLT)—all with a minimum of two years’ follow-up data—found 22 percent of patients develop recurrent varicose veins after ablation of the great saphenous vein (GSV). This figure is similar to the recurrence rate in patients undergoing ligature and stripping.  
Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now